RDY DR REDDYS LABORATORIES LTD
NEUTRAL
Impact: 2/10
6-K
Notable filing: 6-K
Price Chart
Loading chart...
Executive Summary
Dr. Reddy's filed a routine 6-K reporting the allotment of 12,100 equity shares upon exercise of stock options under existing ESOP schemes. This is a standard administrative disclosure with no material financial impact.
Actionable Insight
No trading action warranted. This is a routine ESOP exercise disclosure with negligible dilution. Monitor upcoming quarterly results for any operational updates.
Key Facts
- Allotted 12,100 equity shares of Re.1 each on June 5, 2026, under Dr. Reddy's Employees Stock Option Scheme, 2002 and Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
- Exercise price was Re.1 per share with no premium.
- Total issued shares after allotment: 83,46,70,070 equity shares.
- The shares rank pari passu with existing shares.
Financial Impact
Minimal — 12,100 shares represent less than 0.00015% of total outstanding shares, with no premium received.
dilution
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
52% bullish (44 analysts)
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000406 |
| Document: 0001575872-26-000406-index.html | 0001575872-26-000406 |
| Document: 0001575872-26-000406.txt | 0001575872-26-000406 |
23 reports for RDY
33%
Hit rate
best @ T+5▲ +0.07%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
4d ago
|
6-K
| $13.45 awaiting T+1 | awaiting T+1 | — | $13.30 (−1.08%) |
|
Jun 5, 2026
9d ago
|
6-K
| $13.29 awaiting T+1 | awaiting T+1 | — | $13.30 (+0.11%) |
|
Jun 3, 2026
11d ago
|
6-K
| $13.02 $13.24 | ▲ +1.69% | ▲ +1.29% | $13.30 (+2.15%) |
|
Jun 1, 2026
13d ago
|
6-K
| $13.26 $13.03 | ▼ −1.73% | ▼ −1.88% | $13.30 (+0.30%) |
|
Jun 1, 2026
13d ago
|
6-K
| $13.26 $13.03 | ▼ −1.73% | ▼ −1.88% | $13.30 (+0.30%) |
|
May 29, 2026
16d ago
|
20-F
| $13.26 $13.03 | ▼ −1.73% | ▼ −1.88% | $13.30 (+0.30%) |
|
May 28, 2026
17d ago
|
6-K
| $13.52 $13.63 | ▲ +0.81% | ▲ +0.57% | $13.30 (−1.63%) |
|
May 28, 2026
17d ago
|
6-K
| $13.52 $13.63 | ▲ +0.81% | ▲ +0.57% | $13.30 (−1.63%) |
|
May 18, 2026
27d ago
|
6-K
| $13.60 $13.45 | ▼ −1.10% | ▼ −0.45% | $13.30 (−2.21%) |
|
May 18, 2026
27d ago
|
6-K
| $13.60 $13.45 | ▼ −1.10% | ▼ −0.45% | $13.30 (−2.21%) |
Showing 10 of 23
US Market Status
Market Closed — Opens in 4h 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access